SEARCH   
MEMBER LOGIN    
Top 500

Pharmaceutical Product Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pharmaceutical Product Manufacturing Market Research Report | ANZSIC C1841 | Jun 2016

Bitter pill: The patent cliff and low-cost overseas manufacturers have hurt industry revenue

IBISWorld’s Pharmaceutical Product Manufacturing market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

Report Snapshot
Industry Statistics & Market Size
Revenue
$7bn
Annual Growth 11-16
-4.9%
Annual Growth 16-21
Add to Cart
Profit
Add to Cart
Employment
13,800
Businesses
337
Industry Analysis & Industry Trends

Major global pharmaceutical groups dominate the Pharmaceutical Product Manufacturing industry, although only a few manufacture active pharmaceutical ingredients in Australia. Increasingly, firms have been limiting their local activities to the later stages of the manufacturing process, such as dispensing, packaging and fill-finish. Many global manufacturers have also been restricting their Australian activities to distribution.

Domestic industry players have had to contend with the effects of the patent cliff, which has been part of a global trend. Losing exclusive manufacturing rights to some of their most profitable drugs has driven industry participants to adopt new business models to survive... purchase to read more

Industry Report - Starting a New Business Chapter

Substantial barriers to entry to the industry exist, not least of which is the fact that the industry is becoming increasingly globalised, with the dominant major players operating on a large global scale. The high and rising costs of R&D, combined with declining R&D productivity pose another substantial obstacle. A new medicine can cost as much as US$2.6 billion to develop with a 10 to 15 year time frame before it makes it to market. Furthermore according to Medicines Australia, it can then take 22 months to get a new medicine listed on the PBS. High capital expenditure is also required at the onset to establish a manufacturing plant geared to producing high-cost, high-technology drugs.

Government policies can be significant barriers to entry... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Pharmaceutical Product Manufacturing Industry?

The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Industry activities include manufacturing active pharmaceutical ingredients and synthesising chemical ingredients, as well as late-stage packaging and fill-finish activities.

Industry Products
Benefit-paid pharmaceuticalsAll other medicationsVitamins and dietary supplementsOTC medicinesOther complementary medicines
 
Industry Activities
Antibacterial, antibiotic and antitoxinVaccineVitamin productHerbal drugAmpoule, medicinal capsule, medicinal ointment and vialBiotechnological pharmaceutical and medicinal productsSerum and blood serumDiagnostic substance


View Sample
Quote
Select Clients